Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
GINKGO BIOWORKS HOLDINGS, INC.
(Name of Issuer)
Class A Common Stock, par value $0.0001 per share
(Title of Class of Securities)
37611X100
(CUSIP Number)
December 31, 2021
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
|
☒ Rule 13d-1(b) |
|
|
|
☐ Rule 13d-1(c) |
|
|
|
☐ Rule 13d-1(d) |
|
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Continued on following pages
Page 1 of 10 Pages
Exhibit Index: Page 9
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 2 of 9 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
ANCHORAGE CAPITAL GROUP, L.L.C.
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
Delaware
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
0
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
0
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
5.28%
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
OO, IA
|
|
|
|||
|
|
|
||||
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 3 of 9 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
ANCHORAGE ADVISORS MANAGEMENT, L.L.C.
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
Delaware
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
0
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
0
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
5.28%
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
OO, HC
|
|
|
|||
|
|
|
||||
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 4 of 9 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
KEVIN M. ULRICH
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
Canada
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
0
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
0
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
69,208,354
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
5.28%
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
IN, HC
|
|
|
|||
|
|
|
||||
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 5 of 9 Pages
|
| Item 1(a). |
Name of Issuer:
|
Ginkgo Bioworks Holdings, Inc. (the “Issuer”)
| Item 1(b). |
Address of Issuer’s Principal Executive Offices:
|
27 Drydock Avenue, 8th Floor Boston, MA 02210
| Item 2(a). |
Name of Person Filing:
|
This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):
| i) |
Anchorage Capital Group, L.L.C. (“Capital Group”);
|
| ii) |
Anchorage Advisors Management, L.L.C. (“Management”); and
|
| iii) |
Kevin M. Ulrich (“Mr. Ulrich”).
|
This statement relates to Shares (as defined herein) held for the account of each of Anchorage Capital Master Offshore, Ltd., a Cayman Islands exempted
company incorporated with limited liability (“ACMO”), AIO V Holdings (Cayman) LLC, a Cayman Islands limited liability company (“AIO V Cayman”), and AIO VI Holdings (Cayman) LLC, a Cayman Islands limited liability company (“AIO VI Cayman”). Capital
Group is the investment advisor to each of ACMO, AIO V Cayman and AIO VI Cayman. Management is the sole managing member of Capital Group. Mr. Ulrich is the Chairman of Capital Group and the managing member of Management.
| Item 2(b). |
Address of Principal Business Office or, if None, Residence:
|
The address of the principal business office of each of the Reporting Persons is 610 Broadway, 6th Floor, New York, NY 10012.
| Item 2(c). |
Citizenship:
|
| i) |
Capital Group is a Delaware limited liability company;
|
| ii) |
Management is a Delaware limited liability company; and
|
| iii) |
Mr. Ulrich is a citizen of Canada.
|
| Item 2(d). |
Title of Class of Securities:
|
Class A Common Stock, par value $0.0001 per share (the “Shares”)
| Item 2(e). |
CUSIP Number:
|
37611X100
| Item 3. |
If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
(e) ☒ An investment adviser in accordance with §240.13d-(b)(1)(ii)(E).
(g) ☒ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
| Item 4. |
Ownership:
|
| Item 4(a). |
Amount Beneficially Owned:
|
As of December 31, 2021, each of the Reporting Persons may be deemed the beneficial owner of 69,208,354 Shares. This amount includes: (i) 250,000 Shares held for the account
of ACMO; (ii) 50,000 Shares the Reporting Persons have the right to acquire upon exercise of warrants (“Warrants”) held for the account of ACMO; (iii) 34,454,177 Shares held for the account of AIO V Cayman; and (iv) 34,454,177 Shares held for the
account of AIO VI Cayman.
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 6 of 9 Pages
|
| Item 4(b). |
Percent of Class:
|
As of December 31, 2021, each of the Reporting Persons may be deemed the beneficial owner of approximately 5.28% of Shares outstanding. (This percentage is based on a total
of 1,310,833,159 Shares outstanding, which is the sum of (1) 1,310,783,159 Shares outstanding on November 8, 2021, as reported in the Issuer’s prospectus on Form 424B3 filed on December 10, 2021, and (2) the 50,000 Shares issuable upon exercise of
the Warrants held for the account of ACMO, which have been added to the number of Shares outstanding pursuant to Rule 13d-3(d)(1)(i) under the Act.)
| Item 4(c) |
Number of Shares of which such person has:
|
|
Capital Group, Management and Mr. Ulrich:
|
|
|
(i) Sole power to vote or direct the vote:
|
0
|
|
(ii) Shared power to vote or direct the vote:
|
69,208,354
|
|
(iii) Sole power to dispose or direct the disposition of:
|
0
|
|
(iv) Shared power to dispose or direct the disposition of:
|
69,208,354
|
| Item 5. |
Ownership of Five Percent or Less of a Class:
|
This Item 5 is not applicable.
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person:
|
See disclosure in Items 2 and 4 hereof. Certain funds identified in Item 2(a) are known to have the right to receive or the power to direct the receipt of dividends from, or
the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:
|
See disclosure in Item 2 hereof.
| Item 8. |
Identification and Classification of Members of the Group:
|
This Item 8 is not applicable.
| Item 9. |
Notice of Dissolution of Group:
|
This Item 9 is not applicable.
| Item 10. |
Certification:
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and
were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having
that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 7 of 9 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
ANCHORAGE CAPITAL GROUP, L.L.C.
|
|||
|
By:
|
/s/ Kevin M. Ulrich
|
||
|
Name:
|
Kevin M. Ulrich
|
||
|
Title:
|
Chairman
|
||
|
ANCHORAGE ADVISORS MANAGEMENT, L.L.C.
|
|||
|
By:
|
/s/ Kevin M. Ulrich
|
||
|
Name:
|
Kevin M. Ulrich
|
||
|
Title:
|
Managing Member
|
||
|
KEVIN M. ULRICH
|
|||
|
/s/ Kevin M. Ulrich
|
|||
|
February 14, 2022
|
|||
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 8 of 9 Pages
|
EXHIBIT INDEX
|
Ex
|
Page No.
|
|
|
A
|
Joint Filing Agreement
|
10
|
|
CUSIP No. 37611X100
|
SCHEDULE 13G
|
Page 9 of 9 Pages
|
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Common Stock of Ginkgo Bioworks Holdings, Inc. dated as of
February 14, 2022 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities
Exchange Act of 1934, as amended.
|
ANCHORAGE CAPITAL GROUP, L.L.C.
|
|||
|
By:
|
/s/ Kevin M. Ulrich
|
||
|
Name:
|
Kevin M. Ulrich
|
||
|
Title:
|
Chairman
|
||
|
ANCHORAGE ADVISORS MANAGEMENT, L.L.C.
|
|||
|
By:
|
/s/ Kevin M. Ulrich
|
||
|
Name:
|
Kevin M. Ulrich
|
||
|
Title:
|
Managing Member
|
||
|
KEVIN M. ULRICH
|
|||
|
/s/ Kevin M. Ulrich
|
|||
| February 14, 2022 | |||